In a 35-year-old woman with systemic lupus erythematosus presenting with an acute right-sided pyramidal syndrome, fever, anemia, thrombocytopenia, and worsening renal function despite normal urinalysis and blood pressure, what is the most likely diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Most Likely Diagnosis: Thrombotic Thrombocytopenic Purpura (TTP)

The most likely diagnosis in this patient is thrombotic thrombocytopenic purpura (TTP), given the constellation of acute neurological deficit (pyramidal syndrome), fever, anemia, thrombocytopenia, and worsening renal function despite normal urinalysis and blood pressure. 1

Diagnostic Reasoning

Why TTP is Most Likely

The clinical presentation strongly suggests a thrombotic microangiopathy (TMA), and among the TMA etiologies in SLE patients, TTP is the prime consideration here:

  • Acute neurological manifestations (right-sided pyramidal syndrome) are characteristic of TTP, occurring in the majority of patients and representing microvascular thrombosis in the CNS 2
  • Fever is present, which occurs in TTP presentations
  • Anemia with thrombocytopenia indicates microangiopathic hemolytic anemia
  • Worsening renal function occurs in TTP due to microvascular thrombosis
  • Normal urinalysis is the critical distinguishing feature—this argues AGAINST lupus nephritis, which would show active sediment with proteinuria and hematuria 3
  • Normal blood pressure also argues against lupus nephritis, which typically presents with hypertension 4

Why Other Diagnoses Are Less Likely

Lupus nephritis (option c) is excluded by the normal urinalysis and normal blood pressure. Active lupus nephritis would show proteinuria, hematuria, and active urine sediment 1, 4. The KDIGO 2024 guidelines emphasize that urinalysis abnormalities are essential for lupus nephritis diagnosis 1.

Antiphospholipid syndrome (option e) typically causes large vessel thrombosis (stroke from arterial occlusion), not the acute pyramidal syndrome with fever and systemic features seen here. While APS can cause microvascular thrombosis (APS nephropathy), it would not explain the acute neurological syndrome with fever and the full TMA picture 1.

Transverse myelitis (option a) could explain the pyramidal syndrome but would not account for the fever, anemia, thrombocytopenia, and renal dysfunction.

Urinary tract infection (option d) is ruled out by normal urinalysis.

Immediate Management Algorithm

Step 1: Urgent Testing While Initiating Treatment

Do not wait for confirmatory testing before starting treatment—TTP has high mortality without immediate intervention 1, 2:

  1. Draw blood immediately for:

    • ADAMTS13 activity and anti-ADAMTS13 antibodies
    • Antiphospholipid antibodies
    • Peripheral blood smear (look for schistocytes)
    • LDH, haptoglobin, reticulocyte count, indirect bilirubin
    • Direct Coombs test

  2. Calculate PLASMIC score (Platelet count, hemoLysis variables, absence of Active cancer, absence of Stem-cell transplant, MCV, INR, Creatinine) 1:

    • Score >5 points = intermediate-to-high risk of TTP
    • Score 0-4 points = low risk

Step 2: Initiate Treatment Immediately in Adults

If PLASMIC score is ≥5 (intermediate-to-high risk), start treatment immediately without waiting for ADAMTS13 results 1:

  • Plasma exchange (daily, continuing until platelet count normalizes for 2-3 days)
  • High-dose glucocorticoids (methylprednisolone 1 g IV daily for 3 days, then prednisone 1 mg/kg/day) 1, 5
  • Hematology consultation immediately—delay in treatment increases mortality 5

Step 3: Confirm Diagnosis and Adjust Treatment

Once ADAMTS13 results return:

  • ADAMTS13 activity <10% confirms TTP 1, 6

    • Add rituximab (375 mg/m² weekly for 4 weeks) 1
    • Consider caplacizumab (von Willebrand factor inhibitor) if available 1, 6

  • ADAMTS13 activity normal + positive antiphospholipid antibodies = APS nephropathy

    • Switch to anticoagulation with warfarin (target INR 2-3) 1
    • Continue glucocorticoids
    • Consider plasma exchange for catastrophic APS 1

  • ADAMTS13 activity normal + negative antiphospholipid antibodies = evaluate for other TMA causes

    • Check complement levels (C3, C4, CH50) for complement-mediated TMA 1
    • Consider eculizumab for complement-mediated TMA 1

Critical Pitfalls to Avoid

  1. Do not delay plasma exchange while waiting for ADAMTS13 results in high-risk patients—this is the most common fatal error 5, 2

  2. Do not assume lupus nephritis based on SLE history alone—the normal urinalysis excludes this diagnosis 1, 4

  3. Do not use direct oral anticoagulants (DOACs) if APS is confirmed—warfarin is superior for preventing thrombotic events in APS 1

  4. Do not transfuse platelets unless life-threatening bleeding—platelet transfusion may worsen thrombosis in TTP 2

  5. In children, defer plasma exchange for 24-48 hours until ADAMTS13 results available (unlike adults) due to higher morbidity of the procedure 1

Distinguishing Features Summary

Feature TTP Lupus Nephritis APS
Urinalysis Normal or minimal changes Active sediment, proteinuria, hematuria Normal or minimal proteinuria
Blood pressure Normal or mildly elevated Usually elevated Variable
Neurological Acute, fluctuating deficits Rare Large vessel stroke
Fever Common Uncommon Uncommon unless catastrophic
ADAMTS13 <10% Normal Normal

The combination of acute neurological deficit, fever, cytopenias, renal dysfunction, and normal urinalysis in an SLE patient creates a high pretest probability for TTP requiring immediate plasma exchange and glucocorticoids 1, 2.

References

Related Questions

In a 21-year-old woman with systemic lupus erythematosus presenting with heavy proteinuria (~6 g/day), normal serum creatinine, hypertension controlled with antihypertensive medications, moderate-to-severe mitral regurgitation, schistocytes on peripheral smear, low complement C3 and C4, high anti‑double‑stranded DNA antibodies by ELISA, negative antiphospholipid antibody workup, and unavailable ADAMTS13 testing, should cyclophosphamide be chosen instead of rituximab for treatment?
A 39-year-old patient with known systemic lupus erythematosus and lupus nephritis on azathioprine and hydroxychloroquine (Plaquenil) presents with one week of diarrhea, headache, and neutropenia on CBC; what is the appropriate management?
In a 50-year-old woman with acute confusion, abnormal eye movements, acute kidney injury, isolated thrombocytopenia, and a negative lumbar puncture, what is the differential diagnosis?
How should I evaluate and manage a 51-year-old woman with systemic lupus erythematosus (SLE) treated for 1.5 years, a history of episodic leukocytosis and fluid‑responsive acute kidney injury, and current use of turmeric, who now presents with burning bilateral lower abdominal pain and a clear thick vaginal discharge?
What is the appropriate initial treatment for a 33-year-old Eastern European woman presenting with bilateral pleural effusions, diffuse ground‑glass opacities, joint pain and stiffness, erythema nodosum, and sicca symptoms (dry eyes and mouth)?
A 28-year-old newly diagnosed with diabetes presents with visual disturbance 12 days after starting treatment, and fundus examination shows no diabetic retinopathy; what is the likely cause and recommended management?
Is there dose tolerance to insulin glargine?
In patients with ventricular premature beats (extrasystoles), when should pharmacologic therapy be initiated and when should invasive interventions such as catheter ablation be performed?
With rapidly falling β‑hCG values (22 → 12 → 7 IU/L) and an ultrasound showing no intrauterine pregnancy, what is the likely diagnosis and recommended management?
In a client with a significant cardiac dysrhythmia, what manifestations indicate decreased cardiac output, and what orders is the provider likely to give?
What is the recommended algorithmic approach for an 83-year-old male with non‑small cell lung carcinoma and elevated thyroid‑stimulating hormone and high free thyroxine levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.